Glenmede Investment Management, LP Edwards Lifesciences Corp Transaction History
Glenmede Investment Management, LP
- $20 Billion
- Q3 2025
A detailed history of Glenmede Investment Management, LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Glenmede Investment Management, LP holds 182,172 shares of EW stock, worth $15.7 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
182,172
Previous 195,671
6.9%
Holding current value
$15.7 Million
Previous $15.3 Billion
99.91%
% of portfolio
0.07%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding EW
# of Institutions
1,465Shares Held
486MCall Options Held
4.26MPut Options Held
1.83M-
Vanguard Group Inc Valley Forge, PA70.4MShares$6.07 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$4.4 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$2.21 Billion0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY25.1MShares$2.16 Billion0.13% of portfolio
-
Wellington Management Group LLP Boston, MA20.8MShares$1.8 Billion0.3% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $53.4B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...